Available standalone or in combination with the firm’s established bioinformatics offerings
Almac’s Diagnostics business unit is now offering Next Generation Sequencing (NGS) data analysis services.
These include professional study design to sample processing and expert data analysis for DNA and RNA samples.
The services are also customisable and available on a standalone basis or in combination with Almac’s established bioinformatics offerings in the areas of biological analysis, biomarker and drug discovery and development and diagnostic product development.
Almac says it will use the latest sequencing technologies and most sophisticated modern computational analysis techniques to ensure optimal results from customer data.
The solutions are delivered through an experienced bioinformatics team from a range of disciplines including biology, medicine, mathematics and biostatistics. The team also has substantial experience in molecular and cell biology, drug discovery and development, and diagnostic product development.
Michael Sloan, vice president of business development for Almac said: ‘NGS is a rapidly maturing technology that continues to demonstrate significant benefits over traditional methods as well as making substantial steps toward routine use in the clinical setting. By expanding our services to include this range of DNA and RNA-Seq analysis we are empowering our customers with the most cutting edge technologies.’